Sensorimotor and Neurocognitive Dysfunctions Parallel Early Telencephalic Neuropathology in Fucosidosis Mice by Stroobants, Stijn et al.
ORIGINAL RESEARCH
published: 12 April 2018
doi: 10.3389/fnbeh.2018.00069
Sensorimotor and Neurocognitive
Dysfunctions Parallel Early
Telencephalic Neuropathology in
Fucosidosis Mice
Stijn Stroobants1,2*, Heike Wolf3, Zsuzsanna Callaerts-Vegh1,2, Thomas Dierks3,
Torben Lübke3 and Rudi D’Hooge1,2
1Laboratory of Biological Psychology, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium,
2mINT Behavioral Phenotyping Facility, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium,
3Biochemistry I, Department of Chemistry, Bielefeld University, Bielefeld, Germany
Edited by:
Nuno Sousa,
Instituto de Pesquisa em Ciências da
Vida e da Saúde (ICVS), Portugal
Reviewed by:
Sulev Kõks,
University of Tartu, Estonia
Volkan Seyrantepe,
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Fucosidosis is a lysosomal storage disorder (LSD) caused by lysosomal α-L-fucosidase
deficiency. Insufficient α-L-fucosidase activity triggers accumulation of undegraded,
fucosylated glycoproteins and glycolipids in various tissues. The human phenotype
is heterogeneous, but progressive motor and cognitive impairments represent the
most characteristic symptoms. Recently, Fuca1-deficient mice were generated by
gene targeting techniques, constituting a novel animal model for human fucosidosis.
These mice display widespread LSD pathology, accumulation of secondary storage
material and neuroinflammation throughout the brain, as well as progressive loss
of Purkinje cells. Fuca1-deficient mice and control littermates were subjected to a
battery of tests detailing different aspects of motor, emotional and cognitive function.
At an early stage of disease, we observed reduced exploratory activity, sensorimotor
disintegration as well as impaired spatial learning and fear memory. These early markers
of neurological deterioration were related to the respective stage of neuropathology
using molecular genetic and immunochemical procedures. Increased expression of the
lysosomal marker Lamp1 and neuroinflammation markers was observed throughout the
brain, but appeared more prominent in cerebral areas in comparison to cerebellum of
Fuca1-deficient mice. This is consistent with impaired behaviors putatively related to
early disruptions of motor and cognitive circuits particularly involving cerebral cortex,
basal ganglia, and hippocampus. Thus, Fuca1-deficient mice represent a practical and
promising fucosidosis model, which can be utilized for pathogenetic and therapeutic
studies.
Keywords: lysosomal storage disorder, fucosidosis, mouse model, neuropathology, behavior, motor function,
learning and memory
INTRODUCTION
Fucosidosis is an inborn error of metabolism that belongs to the family of lysosomal storage
diseases (LSDs; Durand et al., 1966; Van Hoof and Hers, 1968). It is an extremely rare disorder
of which only around 120 cases have been reported worldwide. The disease is caused by
mutations in the FUCA1 gene, which encodes the expression of lysosomal α-L-fucosidase (Willems
et al., 1999). Insufficient activity of this exoglycosidase triggers accumulation of undegraded,
fucosylated glycoproteins and glycolipids in various tissues, particularly the brain. The disease
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phenotype is highly variable, and distinct subtypes have
been proposed based on age of onset and progression rate,
although increasing evidence exists for a clinical continuum.
Fucosidosis progressively affects the central nervous system
(CNS), leading to neurological deterioration. Consequently,
progressive motor and cognitive impairments constitute the
most characteristic symptoms (Willems et al., 1991). Other
typical manifestations include facial coarsening, recurrent
infections, growth retardations, seizures and angiokeratoma. The
detrimental disease course eventually leads to cachexia and often
to early death within the first decade of life (Willems et al., 1999).
Canine fucosidosis described in English Springer Spaniels
is a long-known animal model for the human disorder
(Hartley et al., 1982; Kelly et al., 1983). Affected dogs suffer
from progressive neurovisceral defects, mimicking human
pathology and symptomatology. The dog model has been
valuable in several preclinical studies, gaining new insights
on pathological processes (e.g., Fletcher et al., 2011, 2014;
Kondagari et al., 2011b,c; Fletcher and Taylor, 2016) and
potential treatment (e.g., Taylor et al., 1986, 1992; Ferrara
et al., 1992, 1997; Kondagari et al., 2011a, 2015). However,
there is currently no effective treatment available for the
human disease. The pursuit for therapeutic efficacy is hampered
by practical limitations of such large animal models. Fuca1-
deficient mice were recently generated by gene targeting
techniques, which present a more practical animal model to
study pathogenic events and evaluate experimental therapeutics
(Wolf et al., 2016). These mice completely lack α-L-fucosidase
activity and develop widespread lysosomal storage pathology
leading to progressive neurological symptoms similar to human
fucosidosis. Comprehensive behavioral phenotyping of Fuca1-
deficient mice is of crucial importance to allow reliable functional
evaluation of experimental treatments. As affected mice become
less responsive and immobile with age, they are expected to show
deficits in most behavioral paradigms, hindering more specific
interpretations.
In the present study, we therefore aimed to characterize
the new fucosidosis model at an early symptomatic stage
(age 3 months). We hypothesized and confirmed subtle
deficits in motor and cognitive read-outs, identifying sensitive
behavioral measures for future therapeutic studies. We further
expected regional differences in neuropathology, which could
be associated with specific intact and impaired behaviors.
Considering the selective loss of Purkinje cells in later stages of
disease, we also focused on comparing cerebral and cerebellar
pathology. Using quantitative PCR, immunoblotting and
immunofluorescence techniques, we included brain region-
specific assessments of storage pathology, inflammation,
neuronal density and myelination.
MATERIALS AND METHODS
Animals
Fuca1-deficient mice were generated as described previously
(Wolf et al., 2016). All experiments were performed in 3-month-
old Fuca1-deficient and age-matched wildtype (WT) littermates
Behavioral assessment was performed in 15WT and 15 knockout
(KO)mice (all females). Mice were housed at standard laboratory
conditions (12 h light/dark cycle, constant room temperature and
humidity). Behavioral testing took place during the light phase of
the cycle. Food and water were available ad libitum. Experimental
protocols were approved by the ethical research committee of
the KU Leuven or other relevant authorities, according to EC
guidelines.
cDNA Synthesis and Real-Time PCR
For RNA preparation, 100 mg (fresh weight) tissue was
disrupted and simultaneously homogenized using a rotor-stator
homogenizer (Ultra-Turrax, IKA, Staufen, Germany). Total
RNA was isolated using RNeasy Midi Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. cDNA
synthesis was carried out using the iScript Kit from Bio-Rad
(Hercules, CA, USA). The relative expression of various gene
products was normalized to Gapdh applying the comparative
CT method (2∆∆CT) in a StepOne Plus Real-Time PCR cycler
(Thermo Fisher Scientific, Waltham, MA, USA) using the KAPA
SYBR Fast Universal Kit (peqlab, VWR, Erlangen, Germany). All
used primer pairs to determine transcript levels are listed below:
Ccl3-forward:
GCAACCAAGTCTTCTCAGCG
Ccl3-reverse:
CAGTTCCAGGTCAGTGATGTATTC
GFAP-forward:
AAGGTTGAATCGCTGGAGGA
GFAP-reverse:
GCTGTGAGGTCTGGCTTGG
CD68-forward:
TGGATTCAAACAGGACCTACATC
CD68-reverse:
TGAATGTCCACTGTGCTGC
Iba1-forward:
GGATCAACAAGCAATTCCTCG
Iba1-reverse:
AACTCCATGTACTTCACCTTGA
Plp1-forward:
GCTGAGTTCCAAATGACCTTCC
Plp1-reverse:
TGAAGGTGAGCAGGGAAACT
MBP-forward:
GTACAAGGACTCACACACGA
MBP-reverse:
CTTGGGATGGAGGTGGTGT
Gapdh-forward:
GCAGTGCCAGCCTCGTCCC
Gapdh-reverse:
CAGGCGCCCAATACGGCCA
Tissue Homogenates
Mouse tissue (150 mg) was homogenized in a 20-fold volume
of TBS containing 0.5% Triton X-100 (v/v) as well as protease
inhibitors by five strokes with a Teflon pestle using a Potter
S homogenizer (Braun, Melsungen, Germany) followed by
subsequent sonification at 4◦C (3 × 20 s pulses, 40% intensity;
Sonifier 450, Branson Ultrasonics, Danbury, CT, USA). After
incubation on ice for 30 min, the homogenates were centrifuged
at 18,000 g for 15 min at 4◦C. The supernatant was further
used for immunoblotting. Protein concentration was determined
using the DC Protein Assay (Bio-Rad).
Immunoblotting
Immunoblotting was carried out under standard conditions
using 4%–20% precast SDS-gels (Bio-Rad) blotted on PVDF
membranes (Merck, Darmstadt, Germany). After incubation
with primary antibodies overnight (Lamp1 (clone 1D4B):
1:250 Developmental Studies Hybridoma Bank (University of
Iowa, IA, USA), Gapdh: 1:250 (sc-25778, Lot #H0612, Santa
Cruz Biotechnology, Dallas, TX, USA); GFAP-glial fibrillary
acidic protein (1:2000; clone G-A-5, G3893, Sigma); myelin
basic protein (1:1000; MAB386, Millipore); NeuN (1:2000;
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clone A60, MAB377, Millipore, Merck, Darmstadt, Germany))
and washing, membranes were incubated for 1 h with the
appropriate secondary antibody conjugated to horseradish
peroxidase (1:5000, Invitrogen, Carlsbad, CA, USA) and were
analyzed by enhanced chemiluminescence (ECL) signals.
Immunofluorescence
Methods for tissue fixation, preparing of free-floating sections
using a Leica 9000s microtome (Leica, Wetzlar, Germany)
and subsequent immunofluorescence staining were performed
as described previously (Kowalewski et al., 2015). Primary
antibodies used by immunofluorescence: glial fibrillary acidic
protein-GFAP (1:500; clone G-A-5, G3893, Sigma); NeuN
(1:1000; clone A60, MAB377, Millipore, Merck, Darmstadt,
Germany), CD68 (1:500; clone FA-11 (MCA1957, AbD Serotec),
myelin basic protein (1:500; MAB386, Millipore), Lamp1
(1:500; clone 1D4B, Developmental Studies Hybridoma Bank
(University of Iowa, Iowa City, IA, USA)). Monoclonal antibody
against GM2 gangliosides (IgM frommouse) was a kind gift from
Prof. Kostantin Dobrenis. Secondary antibodies: AlexaFluor-
coupled antibodies (1:2000) were purchased from Invitrogen.
Nuclei were stained with DAPI (Sigma). Confocal microscopy
was carried out with a LSM 700 (Zeiss, Oberkochen, Germany)
or Olympus FV1000 microscope (Tokyo, Japan).
Motor Behavior
Sensorimotor integration was assessed with the balance beam
test. Mice were trained to walk across a set of 1 m long
narrow beams. Six beams were used which shape and diameter
represented increasing challenge for balance and equilibrium
(square (SQ), cross-section: 28, 12 and 5 mm; round (RO),
diameter: 28, 17 and 11 mm). Beams were placed 50 cm above
surface, terminating on a square escape platform. During the
training phase, mice learned to traverse the 12 mm square beam
in straightforward motion. Training was completed when all
subjects reached the predetermined criterion of 20 s traversal
latency. All mice reached this criterion within four training trials.
Testing comprised two consecutive trials on each of the beams
in the order described above. Latency to cross (cut-off 60 s)
and number of hind paw slips were recorded for each trial. The
average of both trials was used for analysis.
Exploratory Behavior
Exploratory behavior was first evaluated by analyzing open field
locomotion. Following 30 min dark adaptation, mice were placed
individually in a transparent 50 × 50 × 30 cm arena. The set-up
was placed on a transparent shelf inside an enclosure and lighting
was provided from below. Subsequent to 1 min habituation,
animal movement was recorded for 10 min using ANY-mazeTM
Video Tracking System software (Stoelting Co., IL, USA). Several
parameters were extracted, including total path length, corner
entries, time in center (=30 cm circle) and % path length in the
center.
Anxiety-related exploration was further assessed in an
elevated plus maze. The arena consisted of a plus-shaped maze,
elevated 50 cm above surface, with two arms (5 cm wide) closed
by side walls and two arms without walls. Mice were placed
in the maze at the crossing of the four arms and could freely
explore for 11 min (1 min habituation + 10 min test). Four IR
beams recording open and closed arm entries, and one recording
the percentage of time per min spent in the open arms were
connected to a computerized activity logger.
Learning and Memory
Working memory was assessed during exploration of a Y-maze
consisting of three arms (5 cm wide, 30 cm long and enclosed
by 30 cm high wall made of gray plastic). Mice were placed in
the center for 10 min exploration of all arms. Locomotion was
observed by a webcam connected to a screen. Entries into all arms
were noted and an alternation was counted if an animal entered
three different arms consecutively. Percentage of spontaneous
alternation visits was calculated as an index of working memory.
Spatial learning and memory was tested in the Morris
water maze task with hidden escape platform. Throughout the
experiment, swimming paths of the mice were recorded using
EthoVision video tracking equipment and software (Noldus,
Wageningen, Netherlands). We used a 150 cm circular pool
filled with water (constant temperature: 26◦C) which was
opacified with AcusolTM OP 301 opacifier (Dow Europe, Horgen,
Switzerland). A 15 cm round platform was hidden 1 cm beneath
the surface of the water at a fixed position. Mice learned to
navigate to the escape platform using different visuo-spatial cues
present in the room. Daily trial blocks of four swimming trials
(intertrial interval 15 min) were performed, starting randomly
from each of four starting positions. Mice that failed to find
the platform within 2 min were guided to the platform. They
had to remain on the platform for 10 s before being rescued
and returned to their home cage (maximum three attempts for
completing 10 s). Path length, escape latency, swimming velocity
and floating behavior (velocity <5 cm/s) were extracted to
assess spatial learning during acquisition trials. Two acquisition
sessions of five trial blocks were each followed by 2 days of
rest and a probe trial. During these probe trials, the platform
(=target) was removed, and the animals were placed in the
pool for 100 s. Time in target quadrant, virtual escape latency,
average distance to target, swimming velocity and floating
were extracted to assess long-term memory for the platform
location. Mice exhibiting over 15% of floating time during a
probe trial were excluded from probe trial analysis to allow
more reliable assessment of spatial memory (final n: WT = 12,
KO = 7).
Passive avoidance learning was examined in a step-through
box with a small illuminated compartment and a larger
dark compartment containing a grid-floor. After 30 min dark
adaptation, the mouse was placed in the light compartment
for a training trial. After 5 s, the sliding door to the
dark compartment was opened and step-through latency
was manually recorded up to a 300-s cut-off. When all
four paws were placed on the grid, a mild electric shock
(0.3 mA, 1 s) was delivered with a constant current shocker
(MED Associates Inc., St. Albans, VT, USA). Retention
memory was tested 24 h later using the same procedure
without shock delivery. Mice which did not enter the dark
compartment before the 300 s cut-off during the training
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FIGURE 1 | Increased Lamp1 expression in the brain of Fuca1-deficient mice. (A) Immunofluorescence staining of brain sections from 3-month-old mice showed an
increase in the lysosome-associated membrane protein 1 (Lamp1) in the cerebellum, hippocampus, motor cortex and striatum of Fuca1-deficient animals. Scale
bars = 200 µm and 50 µm for magnifications of the hippocampus (CA1). Insets represent further magnifications of the boxed areas, clearly illustrating increased
Lamp1 immunoreactivity in Fuca1-deficient mice. Nuclei were stained with DAPI. (B) Immunoblotting of tissue homogenates from 3-month-old mice revealed an
increased amount in Lamp1 in the cerebrum but not in the cerebellum of Fuca1-deficient mice (mean ± SD, n = 3). Gapdh was used for normalization. Asterisk
indicates significance of difference.
trial (three Fuca1-deficient mice) were excluded from final
analysis.
Statistics
Western blots (mean ± SD) were analyzed using two-tailed
t-test (Microsoft Excel, Microsoft Corporation Redmont,
WA, USA). Real-time PCR data were analyzed by unpaired
t-test using GraphPad QuickCalcs, GraphPad Software, La
Jolla, CA, USA). Behavioral data are presented as mean
+ standard error of the mean (SEM). Shapiro-Wilk and
Brown-Forsythe tests were used to determine normality and
variance homogeneity. Group comparisons were performed
through unpaired t-tests, Mann-Whitney rank sum tests or
2-way repeated-measures ANOVA taking into consideration
dependent variable characteristics. ANCOVA was used to
take into account covariates in the analysis of water maze
performance. The Holm-Sidak method was used for multiple
comparison procedures. The significance threshold was set at
α = 0.05.
RESULTS
Neuropathological Description of
3-Month-Old Fuca1-Deficient Mice
In order to correlate our behavioral observations in young
adult Fuca1-deficient mice to the status of neuropathology, we
assessed brain region-specific alterations at different levels using
quantitative PCR, immunoblotting and immunofluorescence
techniques (n = 3). We specifically assessed the expression
of markers relevant for lysosomal storage disorder (LSD)
pathogenesis, reflecting enlargement of the lysosomal system,
neuroinflammation, myelination, neuronal density and
secondary storage.
Immunofluorescence staining for the lysosome-associated
membrane protein (Lamp1) at the age of 3 months in Fuca1-
deficient mice indicated elevations of Lamp1 expression
in all investigated brain regions: cerebellum, hippocampus,
motor cortex and striatum. Hippocampus and motor cortex
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FIGURE 2 | Increased expression of neuroinflammation markers in Fuca1-deficient mouse brains. (A) Quantitative PCR analysis of mRNA cerebrum and cerebellum
revealed increased transcript levels for CD68, Iba1 and GFAP in 3-month-old Fuca1-deficient mice. (B) Tissue homogenates from cerebrum and cerebellum were
separated by SDS-PAGE and blotted onto PVDF membrane. After blotting, the membrane was cut and the part of the membrane representing proteins larger than
25 kDa was analyzed for GFAP. An apparent increase in GFAP protein was found in the cerebrum but not in the cerebellum of 3-month-old Fuca1-deficient mice as
shown by immunoblotting of tissue homogenates (mean ± SD, n = 3), but both comparisons did not reach significance. Gapdh was used for normalization.
Immunofluorescence staining showed elevated amounts of CD68 (C) and GFAP (D) in the cerebellum, hippocampus, motor cortex and the dorsal striatum of
3-month-old Fuca1-deficient mice. The cell nuclei were stained with DAPI. Scale bars = 200 µm. Asterisk indicates significance of difference.
appeared strongly affected, while no obvious differences
were observed between hippocampal (CA1-CA3-dentate
gyrus) or striatal (dorsal vs. ventral) subregions (Figure 1A).
Immunoblotting of tissue homogenates corroborated these
observations, revealing a significantly increased amount of
Lamp1 in the cerebrum of Fuca1-deficient mice (p < 0.05),
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FIGURE 3 | Reduced Plp1 and MBP mRNA expression but intact myelination in the brain of Fuca1-deficient mice. (A) Quantitative PCR analysis of mRNA from
cerebrum and cerebellum revealed decreased levels of Plp1 and MBP in 3-month-old Fuca1-deficient mice. (B) Tissue homogenates from cerebrum and cerebellum
were separated by SDS-PAGE and blotted onto PVDF membrane. After blotting, the membrane was cut and the part of the membrane representing proteins smaller
than 25 kDa was analyzed for MBP. The amount of MBP was not significantly lower in the Fuca1 gene knock-out as shown by immunoblotting of cerebral and
cerebellar tissue homogenates of 3-month-old mice (mean ± SD, n = 3). Gapdh was used for normalization. The Gapdh results shown here and in Figure 2B are
identical, as the same blot was used for the analyses. (C) Myelination is unaffected in the Fuca1 gene knock-out as shown by immunofluorescence staining of MBP
in brain sections of 3-month-old mice. The cell nuclei were stained with DAPI. Scale bars = 200 µm (cerebellum (left panel) and striatum) or 50 µm (cerebellum (right
panel) and corpus callosum). Asterisk indicates significance of difference.
while the difference did not reach significance in the cerebellum
(Figure 1B).
Different neuroinflammation markers were analyzed on
multiple levels at the age of 3 months. Analysis of mRNA
from cerebrum and cerebellum indicated highly increased
transcription levels (3- to 9-fold) in Fuca1-deficient mice for
the microglia/macrophage marker CD68 (p < 0.005), and
the astrocytic marker GFAP (p < 0.0001) while expression
of the microglia/macrophage-specific protein Iba1 was just
moderately elevated in cerebrum (2.3-fold, p < 0.005) and
cerebellum (2-fold, p < 0.001; Figure 2A). Further, the
mRNA of macrophage inflammatory protein Ccl3 was detected
at significant levels in both cerebrum and cerebellum of
Fuca1-deficient mice, while it was hardly detectable (about
10- to 20-fold reduced) in WT tissues (data not shown).
Western blot analysis indicated an increased, albeit not
significantly, GFAP level in cerebrum of Fuca1-deficient
mice, whereas GFAP levels were not altered in cerebellum
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FIGURE 4 | Fuca1-deficient mouse brains show normal levels of NeuN protein. (A) Immunofluorescence staining of brain sections from 3-month-old mice showed
no alterations in NeuN protein in the cerebellum, hippocampus, motor cortex and dorsal striatum of Fuca1-deficient animals. Scale bars = 200 µm. (B) The amount
of NeuN protein is unaffected in the Fuca1 gene knock-out as shown by immunoblotting of cerebral and cerebellar tissue homogenates from 3-month-old mice
(mean ± SD, n = 3). Gapdh was used for normalization.
(Figure 2B). Immunofluorescence analysis revealed a massive
increase in staining for CD68 (Figure 2C) and GFAP
(Figure 2D) throughout all inspected brain regions (cerebellum,
hippocampus, motor cortex, striatum and prefrontal cortex).
Notably, the increase in GFAP immunoreactivity was more
prominent in cerebral compared to cerebellar areas. Within
the cerebellum, GFAP staining appeared most pronounced in
Purkinje cell perikarya and dendritic trees.
Quantitative PCR analysis of mRNA from cerebrum and
cerebellum indicated decreased levels of the myelin markers Plp1
(p < 0.005) and MBP (p < 0.0001) in Fuca1-deficient mice
(15%–45% reductions; Figure 3A). However, immunoblotting
of cerebral and cerebellar tissue homogenates did not confirm
a significant reduction in MBP protein levels (Figure 3B). MBP
immunofluorescence staining did not show apparent differences
in myelination in cerebellum, corpus callosum and striatum of
Fuca1-deficient mice (Figure 3C). Likewise, no differences in
immunoreactivity were observed for the neuron-specific marker
NeuN by immunofluorescence or Western blotting, suggesting
an intact neuronal density at the age of 3 months in Fuca1-
deficient mice (Figures 4A,B).
Immunofluorescence staining for GM2 ganglioside indicated
moderate secondary lipid accumulation in cerebellum,
hippocampus, striatum and cerebral cortex in 3-month-old
Fuca1-deficient mice (Figure 5). Secondary storage intensity
showed no obvious changes in different investigated subregions
(CA3-CA1-DG; motor and prefrontal cortex).
Behavioral Assessment of 3-Month-Old
Fuca1-Deficient Mice
Sensorimotor Disintegration
In the balance beam test, mice learned to walk across a
series of wooden beams to evaluate equilibrium and motor
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FIGURE 5 | Fuca1-deficient mice exhibit accumulation of GM2 ganglioside throughout the brain. Representative immunofluorescence staining of brain sections from
3-month-old mice showed signs of GM2 ganglioside accumulation in all analyzed regions (cerebellum, hippocampus, cerebral cortex, striatum) of the Fuca1-deficient
brain. Magnified images of boxed areas illustrate prominent secondary lipid storage. Scale bars = 200 µm. Nuclei were stained with DAPI.
coordination. Fuca1-deficient mice presented hesitant and
unbalanced. They traversed the beams significantly slower to
reach the escape platform (Figure 6A). Increased traversal
latencies were observed for all beam shapes and widths
(SQ1: t = 3.29, p < 0.01; SQ2: t = 3.56, p < 0.01; SQ3:
t = 4.16, p < 0.01; RO1: t = 4.30, p < 0.001; RO2:
t = 3.21, p < 0.01; RO3: t = 3.28, p < 0.01). Furthermore,
Fuca1-deficient mice committed more paw slips than WT
controls, depending on beam difficulty (Figure 6B). Paw slips
were not significantly increased for the widest square beam
(SQ1: p = 0.11), in contrast to more challenging beams
(SQ2: U = 46.5, p < 0.01; SQ3: U = 45.0, p < 0.01; RO1:
U = 51.0, p < 0.01; RO2: t = 4.99, p < 0.001; RO3: U = 52.0,
p < 0.05).
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FIGURE 6 | Fuca1-deficient mice display impaired balance beam performance but no significant changes in open field behavior. (A,B) Balance beam performance in
3-month-old Fuca1-deficient mice (Fuca1 -/-, gray bars) and age-matched wildtype (WT) littermates (black bars). Fuca1-deficient mice were slower to traverse all
square and round beam types in the balance beam test (A). They also made significantly more paw slips in comparison to WT littermates on all beams except SQ1
(B). (C,D) Open field behavior in 3-month-old Fuca1-deficient mice (Fuca1 -/-, gray bars) and age-matched WT littermates (WT, black bars). No significant changes
were observed during open field exploration in 3-month-old Fuca1-deficient mice in comparison to WT animals, as illustrated by total path length (C) and the relative
distance traveled in the center of the arena (D). All data are presented as mean ± standard error of the mean (SEM; both genotypes n = 15). Abbreviations: BB,
balance beam; SQ, square; RO, round; OF, open field. Asterisk indicates significance of difference.
Context-Specific Reduction of Exploratory
Locomotion
Explorative locomotion and specific exploratory patterns were
assessed in an open field arena. Fuca1-deficient mice showed no
significant decline in total distance traveled (Figure 6C: p = 0.32).
Furthermore, no significant differences were observed in spatial
exploration patterns. Both genotypes showed similar % path
length in the center (Figure 6D: p = 0.14). Likewise, no difference
were observed for corner entries (p = 0.31) and time in the
center (p = 0.22). Respective parameters were also analyzed in
1 min intervals revealing no time-dependent differences between
genotypes (not shown).
Exploration and anxiety was further evaluated in the elevated
plus maze. Total beam crossings indicated a tendency for
reduced activity in Fuca1-deficient mice (Figure 7A: p = 0.08).
No difference was observed in exploration of open vs. closed
arms. Both genotypes showed comparable percentage of activity
(Figure 7B: p = 0.79) and time (Figure 7C: p = 0.99) spent
in the open arms. Respective parameters were also analyzed in
1 min intervals revealing no time-dependent differences between
genotypes (not shown).
However, during exploration of the Y-maze, Fuca1-deficient
mice made significantly less arm visits than WT controls
(Figure 7D; U = 55.5, p < 0.05). The majority of KO mice
did not make sufficient arm entries for calculation of the
alternation percentage. This lack of explorative locomotion
precluded genotype comparisons for the cognitive aspect of the
task.
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FIGURE 7 | Fuca1-deficient mice show reduced exploratory activity but no changes in anxiety levels. (A–C) Elevated plus maze exploration in 3-month-old
Fuca1-deficient mice (Fuca1 -/-, gray bars) and age-matched WT littermates (black bars). Total beam crossings tended to be decreased in Fuca1-deficient mice (A),
but relative exploratory activity (B) and time (C) in open vs. closed arms was similar to WT littermates. (D) Y-maze exploration in 3-month-old Fuca1-deficient mice
(Fuca1 -/-, gray bar) and age-matched WT littermates (WT, black bar). Fuca1-deficient mice were significantly less active in the Y-maze. The low amount of arm visits
precluded assessment of spontaneous alternations for evaluation of working memory. All data are presented as mean ± SEM (both genotypes n = 15).
Abbreviations: EPM, elevated plus maze. Asterisk indicates significance of difference.
Impaired Swimming Performance, Spatial Learning
and Contextual Memory
Spatial learning and memory was evaluated in a Morris-type
water maze. During the acquisition phase, both genotypes
learned to reach the escape platform as indicated by general
reductions in escape latency and path length. However, escape
latencies were significantly higher in Fuca1-deficient mice
(Figure 8A: F = 4.7, p < 0.05), which depended on the
trial block (genotype × trial block interaction: F = 2.9,
p < 0.01). Post hoc comparisons confirmed that Fuca1-
deficient mice were specifically slower during the beginning
of acquisition (Day 1: p < 0.05; Day 2: p < 0.001;
Day 3: p < 0.01 specifically). Likewise, these mice showed a
time-dependent increase of required path length to reach the
platform (Figure 8B: genotype × trial block interaction: F = 3.5,
p < 0.001). The difference in path length was restricted to
Days 2 (p < 0.001) and 3 (p < 0.05) according to post hoc
comparisons.
Swimming velocity was identified as a potential confounding
factor for cognitive performance. Importantly, Fuca1-deficient
mice swam significantly slower during acquisition than WT
littermates (Figure 8C: F = 4.5, p< 0.05), although the difference
again depended on specific trial blocks (F = 2.0, p < 0.05).
Post hoc comparisons revealed significant velocity reductions
during the first 4 days of acquisition (Day 1: p < 0.01; Day
2-3-4: p < 0.05). Notably, both genotypes showed considerable
amounts of floating behavior (very low swimming speed, nearly
immobile), which increased relative to swimming time during
the course of acquisition (Figure 8D). Floating appeared to be
more substantial in Fuca1-deficient mice, but this difference was
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FIGURE 8 | Fuca1-deficient mice display impaired spatial learning during water maze acquisition. (A–F) Morris water acquisition in 3-month-old Fuca1-deficient mice
(Fuca1 -/-, white circles) and age-matched WT littermates (black circles). Fuca1-deficient mice were significantly slower to locate the hidden platform during the first
3 days of acquisition (A, escape latency). Furthermore, they traveled more distance than WT mice before reaching the platform during days 2 and 3 (B, path length).
However, these mice also showed reduced swimming velocity during days 1–4 (C) as well as a tendency for increased immobility (D). Adjusted escape latencies (E)
and path lengths (F) showed residual defects in spatial learning of Fuca1-deficient mice after taking into account variability in swimming velocity (during days 2 and
2–3 respectively). All data are presented as mean ± SEM (both genotypes n = 15). Asterisk indicates significance of difference.
not significant (p = 0.10). Analysis of covariance on velocity
data using floating percentage as covariate did not influence
results (not shown), confirming that the velocity deficit of Fuca1-
deficient mice could not be explained by voluntary immobility.
Considering the potential confounding effects of the lower
swimming velocity of Fuca1-deficient mice, performance
parameters for spatial learning were subjected to analyses of
covariance using daily swimming speed as covariate. The velocity
covariate significantly affected escape latencies from Day 2–10
(Day 2: p < 0.05; Day 3–10: p < 0.001). Taking into account
the variability in swimming velocity, adjusted escape latencies
of Fuca1-deficient mice remained only significantly higher at
Day 2 (Figure 8E: F = 16.7, p < 0.001). On the other hand, the
velocity covariate also significantly influenced path length, but
only during the first 2 days (Day 1: p < 0.05; Day 2: p < 0.01).
Path length adjusted for swimming velocity was very similar
to original measures, with significantly higher path length of
Fuca1-deficient mice during Days 2 and 3 (Figure 8F: Day 2:
F = 27.7, p < 0.001; Day 3: F = 6.4, p < 0.05).
Long-term memory for the platform location was assessed
during weekly probe trials. Only sufficiently mobile animals
were included for this evaluation (see ‘‘Materials and Methods’’
section). During probe trials, no differences in floating behavior
were observed between genotypes (not shown). Latency to reach
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FIGURE 9 | Fuca1-deficient mice display intact spatial but impaired fear memory (A–E). Probe trial performance in 3-month-old Fuca1-deficient mice (Fuca1 -/-,
gray bars) and age-matched WT littermates (WT, black bars). Fuca1-deficient mice were slower to cross the virtual platform zone during the first probe trial (A) but
also swam slower during this trial in comparison to WT littermates (B). Virtual escape latencies were adjusted taking into account variability in swimming velocity,
showing no residual differences (C). Similar probe trial performance was further confirmed by other measures of spatial memory such as time spent in the target
quadrant (D) and average distance to target (E). Importantly, only sufficiently mobile animals were included for probe trial analysis (see “Materials and Methods”
section final n: WT = 12, Fuca1 -/- = 7). (F) Passive avoidance learning in 3-month-old Fuca1-deficient mice (Fuca1 -/-, gray bars) and age-matched WT littermates
(black bars). Step-through latencies of Fuca1-deficient mice did not differ from WT mice during the training phase. During contextual memory assessment 24 h later,
both genotypes showed an increase of step-through latencies, indicating significant retention. However, Fuca1-deficient mice showed significantly reduced latencies
in comparison to WT mice. Notably, three Fuca1-deficient mice were excluded from final analysis as they did not enter the dark compartment during the training trial
(final n: WT = 15, Fuca1 -/- = 12). All data are presented as mean ± SEM. Asterisk indicates significance of difference.
the target area was significantly higher in Fuca1-deficient mice
only during the first probe trial (Figure 9A: U = 16.0, p < 0.05).
However, similar to the acquisition phase, Fuca1-deficient mice
showed significantly reduced swimming velocity during this first
probe trial (Figure 9B: t = 2.26, p < 0.05) and similar tendencies
during the second probe. Analysis of covariance indicated no
difference in adjusted escape latencies taking into account the
variability in swimming velocity (Figure 9C: p = 0.14 and
p = 0.34). Furthermore, more robust indications of spatial
memory such as time spent in the target quadrant (Figure 9D:
p = 0.94 and p = 0.99) and average distance to target (Figure 9E:
p = 0.96 and p = 0.83) showed no differences between the
genotypes in either probe trial. Both genotypes showed clearly
improved retention during the second probe trial.
The passive avoidance test was included as an index
of contextual fear memory. During the training phase, no
significant difference in baseline step-through latency was
observed between genotypes (Figure 9F). Contextual memory
was assessed 24 h later under the same conditions. Both
genotypes showed an increase of step-through latencies,
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indicating significant retention. However, Fuca1-deficient
mice showed significantly reduced step-through latencies in
comparison to WT mice (Figure 9F; U = 46.0, p < 0.05).
DISCUSSION
Fuca1-deficient mice, a promising animal model for human
fucosidosis, were shown to display a progressive disease
course reminiscent of a milder form of the human condition
(Wolf et al., 2016). The model exhibits pathognomonic
CNS pathology, including lysosomal storage, axonal spheroid
formation, neuroinflammation and loss of Purkinje cells.
Presently, we demonstrate behavioral alterations in Fuca1-
deficient mice that coincide with early signs of neuropathology
(age 3 months). We identified subtle changes in sensorimotor
and cognitive abilities, and related these to the status of
neuropathology. Using molecular genetic and immunochemical
techniques, we showed that 3-month-old Fuca1-deficient mice
display lysosomal dysregulation (increased Lamp1 expression),
evidence of neuroinflammation (increased CD68, Iba1 and
GFAP expression) and secondary storage of GM2 ganglioside,
as early manifestations of brain pathology. Secondary lipidosis
constitutes a common hallmark of LSDs and could contribute
to variable disease outcome (Prinetti et al., 2011), but biopsies
of human fucosidosis patients are yet to be investigated for
secondary lipid storage. Myelin defects have been reported in
several LSDs (Folkerth, 1999; Onyenwoke and Brenman, 2015)
including human and canine fucosidosis (Kondagari et al.,
2011b; Miranda et al., 2013). Quantitative PCR analysis indicated
decreased mRNA levels for Plp1 and MBP at 3 months of
age, but we failed to observe significant changes in MBP level
or immunoreactivity, suggesting sufficient MBP synthesis for
myelination processes. Indications of neuron loss were not yet
observed, as NeuN expression was unaltered, but have been
reported in later stages of disease (Wolf et al., 2016).
Fuca1-deficient mice do not show obvious changes in
appearance before the age of 6 months, after which they become
overtly ataxic and immobile. Previous analysis indicated that
reduced grip strength and home cage activity present early
in these mice (Wolf et al., 2016). Motor coordination on the
rotarod appeared unaffected at this stage. In contrast, the balance
beam test currently revealed clear differences between both
genotypes. Fuca1-deficient mice were slower to traverse the
narrow beams and made more paw slips, suggesting reduced
sensorimotor integration. These results identify the balance beam
as an interesting test to quantify motor deficits at an early stage of
disease. It was shown thatmotor behavior strongly deteriorates in
these mice, resulting in impaired rotarod performance at the age
of 7 months. This deterioration correlates with the progressive
loss of Purkinje cells between 3.5 months and 11 months of
age (Wolf et al., 2016). Our present results indicate that the
deficits in beam walking precede this devastating loss of Purkinje
neurons. Several studies reported beam walking to be more
sensitive than rotarod tasks to detect subtle motor deficits (e.g.,
Stanley et al., 2005; Curzon et al., 2009; Luong et al., 2011).
Interestingly, increases in Lamp1 expression as well as expression
of neuroinflammation markers appeared more pronounced in
cerebral (motor) areas in comparison to cerebellar areas. This
may suggest a more prominent role for areas involved in the
cortico-basal ganglia-thalamocortical motor loop (such as e.g.,
motor cortex and dorsal striatum) at this early stage of disease.
Balance beam assessment is considered to be particularly effective
in detecting early signs of basal ganglia dysfunction (Magen
and Chesselet, 2014). Notably, alterations in pallidal and nigral
signaling in brain MRI appear characteristic for fucosidosis
patients in comparison to other LSDs (Provenzale et al., 1995;
Galluzzi et al., 2001; Malatt et al., 2015).
Open field, elevated plus maze and Y-maze are exploration-
based procedures with different target measures. Fuca1-deficient
mice displayed significantly reduced activity in the Y-maze test,
while a similar trend was observed in elevated plus maze. In
contrast, no differences were observed in exploratory patterns in
open field (center vs. corners) or elevated plus maze (open vs.
closed arms), suggesting intact conflict resolution and emotional
function. Reduced ambulation in these tests therefore appears
to reflect general reduction in locomotor activity, consistent
with earlier observations of reduced home cage activity (Wolf
et al., 2016). Notably, the lack of movement by Fuca1-deficient
mice in the Y-maze precluded the assessment of spontaneous
alternations as an index of working memory (Bak et al., 2017).
Spatial learning and memory was subsequently assessed in
a water maze task. Fuca1-deficient mice showed significantly
reduced swimming velocity during acquisition. This constitutes
a potential confounding factor for water maze performance
assessment as it strongly influences latency measures. For
example, Innos et al. (2011, 2012) showed slower swimming but
intact learning in Lsamp-deficient mice, using path length as
performance measure to circumvent velocity differences. These
mice did not show changes in sensorimotor function however,
while the reduced swimming performance of Fuca1-deficient
mice is likely related to a combination of motor problems and
floating behavior. Taking into account variability in swimming
velocity, Fuca1-deficient mice were still slower to locate the
platform during the second day of acquisition. This was indeed
confirmed by the fact that despite signs of reduced mobility,
these mice traveled more distance to reach the platform during
days 2 and 3. These results suggest impaired spatial learning in
3-month-old Fuca1-deficient mice, which is certainly consistent
with already prominent signs of lysosomal perturbation and
neuroinflammation in specifically relevant regions such as
hippocampus, prefrontal cortex and striatum (Pooters et al.,
2015). No major differences in the degree of pathology were
observed in these different (sub)regions, suggesting general
but mild disruption of the neurocircuits involved in spatial
cognition. Analysis of long-term spatial memory in the probe
trials revealed no differences between the genotypes taking into
consideration the differences in swimming velocity. However,
only sufficiently mobile animals were used to allow reliable
assessment of spatial preferences, which may have introduced a
selection bias towards less affected animals. In general, motor
signs are still subtle and our analysis clearly indicates residual
impairment of spatial learning after accounting for swimming
velocity. It could nevertheless be considered to evaluate spatial
cognition in future studies with an allocentric navigation task
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less reliant on coordinated movement, such as the radial arm
maze. Reduced locomotor activity, as observed in some tasks
in our study, could however be an increasingly confounding
factor in dry-land ambulation in comparison to water maze tasks
(Fitzgerald and Dokla, 1989).
Cognitive function was further evaluated in a hippocampus-
dependent non-spatial learning task. In contrast to active
learning paradigms, the passive avoidance task requires
inhibition of movement related to the natural propensity
towards darkness (Piccart et al., 2011). During the training
phase, some Fuca1-deficient mice did not enter the dark
compartment before the cut-off time and were excluded for
the analysis of cognitive performance. This reluctance does
not seem to be related to an altered affective response to light
vs. dark environments, considering the lack of difference in
tests of emotionality. More likely, it is an additional expression
of reduced locomotion. Notwithstanding their hypoactivity,
Fuca1-deficient mice were faster to step through in the test
phase, clearly indicating reduced fear memory 24 h post-
acquisition. These findings confirm the presence of impaired
(contextual) fear memory at the age of 3 months, substantially
earlier than the contextual and cued fear memory deficits
observed in 7-months-old mice (Wolf et al., 2016). Moreover,
this outcome constitutes unequivocal evidence for early
manifestation of cognitive dysfunction in Fuca1-deficient mice.
Importantly, the use of this parameter will allow reliable and
time-dependent evaluation of therapeutic efficacy for a key
neurological symptom of human fucosidosis (Willems et al.,
1991).
Progressive neurological dysfunction in Fuca1-deficient mice
parallels disease progression in the dog model. Recently, Fletcher
and Taylor (2016) performed a meta-analysis on historical
canine fucosidosis records (Kondagari et al., 2011b,c). First
signs of motor and behavioral dysfunction are reported after
6 months, with subtle gait and proprioceptive deficits as well as
apprehensive behaviors becoming consistently increased after
12 months. Further disease progress includes the development
of pronounced ataxia, postural instabilities, failure to learn
and sensory dysfunction. The early proprioceptive deficits in
the dog model are reminiscent of the poor performance of
young Fuca1-deficient mice in beam walking, which requires
successful integration of sensory stimuli during movement
to maintain equilibrium. Predictive statistical analysis further
identified neuroinflammation and apoptotic cell death to be
particularly associated with neurological disease progression in
canine fucosidosis. This appears consistent with an important
contribution of neuroinflammatory processes to cellular
dysfunction and early neurological symptoms in Fuca1-deficient
mice. Human fucosidosis is often characterized by early disease
onset and variable rates of psychomotor regression (Kousseff
et al., 1976). Although disease progression in Fuca1-deficient
mice appears relatively mild in comparison to most human
case reports, our behavioral assessment identified consistent
abnormalities in psychomotor behavior at the age of 3 months.
As this is currently the earliest age behavioral assessment
has been performed, it is unclear to which extent a truly
presymptomatic stage exists in these mice. Therefore, it would be
interesting to evaluate in future studies whether Fuca1-deficient
mice show abnormalities in neurobehavioral development,
as observed in mouse models more directly affected in CNS
development (Stroobants et al., 2017). These evaluations could
yield crucial insights to determine the therapeutic window
of opportunity, as treatments generally become less effective
upon the emergence of neurological symptoms (Matthes et al.,
2012).
In summary, we identified reduced exploratory activity,
sensorimotor disintegration and impaired spatial learning and
fear memory as sensitive markers for early neurological
deterioration in Fuca1-deficient mice. These deficits reflect an
early stage of neuropathology characterized by an extended
endosomal-lysosomal network, secondary lipid storage, and
emerging microgliosis and astrogliosis, but preceding neuron
loss. Fuca1-deficient mice represent a practical and promising
model for human fucosidosis, which can be used for pathogenetic
and therapeutic studies.
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